Benefit of memantine in the treatment of Alzheimer's disease not proven

There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.

Read the whole article on Physorg

More from Physorg